13/09/2017 18:05:41

RxS moves to new location to accommodate rapid growth

MANALAPAN, NJ, Sept. 13, 2017 (GLOBE NEWSWIRE) -- RxS LLC (“RxS”), a privately held company providing multi-channel sample management solutions to pharmaceutical and biotech companies, announced today its move to a new location to accommodate the company’s continued growth and success. Remaining in Manalapan, NJ, RxS is now operating at:

195 Route 9 S., Suite 208

Manalapan, NJ 07726

Pharmaceutical and biotech companies are often burdened by the regulations surrounding sample management, and that’s where RxS comes in. RxS offers customizable solutions for multi-channel sample management to companies of all sizes, ensuring compliance, state-of-the-art reporting, and outstanding customer service. “We are a service organization enabled by technology,” says Mark Jara, Principal, Managing Director. “Because RxS has proven to be a valuable business partner for so many companies, RxS has moved to a new location to accommodate our growth and success.”

RxS has maintained organizational growth year after year, including sales, clients, employees, and services.  Over the past two years they had a surge in new clients and business expansion. The new office space will support RxS’s promising trajectory as well as creating a high tech collaborative environment to optimize customer service and enhance technical development.

The move, however, is just one of several new developments for RxS. Concurrent to this action, the company is continuing the growth of its European footprint. In addition, RxS has entered the planning phase for a proposed satellite location in southeastern Florida slated to open by mid-2018.

RxS has become a leading provider of multi-channel sample management solutions. RxS’s growing presence and continued success is credited to its leadership team that collectively has more than 75 years of pharmaceutical expertise, along with the employees’ immense knowledge and understanding of the pharma and biotech industries. Beyond that, RxS has been built on technology and is committed to providing superior customer service.

By having technology at its core, RxS can provide offerings that ensure Prescription Drug Marketing Act compliance and also supply valuable reporting and analytics data. Customers can access up-to-date reporting and analytics data 24 hours a day, seven days a week, a feature that makes proactive monitoring possible. This results in customers having the tools to advance marketing reach and optimizing sample effectiveness.

Customer service is paramount to the team at RxS. In the client-supplier relationship, the company views itself as a business partner rather than simply a vendor as account representatives learn each client’s needs and provide client centric solutions designed to drive success. RxS has found this to be a most effective approach, as the solutions they provide clients are transparent and value-centric in terms of pricing.

RxS’s success is a direct reflection of the value it has provided and continues to provide its customers. For example, by applying industry experiences and a consultative approach, RxS was able to provide a small-sized client with guidance on best practices, lead-in project management and technical integrations during their first prescription representative product sampling launch. The result was an overwhelming success that relieved the client of startup complexities while achieving compliance through a solid forward thinking framework, on time and on budget.

The value RxS provides customers extends also to more established pharmaceutical and biotech companies. For instance, a client needed to transition from having multiple vendors to a consolidated solution, so RxS provided such a solution and also strategic value during the transition. RxS achieved this by working with numerous internal and external stakeholders to identify scope and requirements. The outcome was a solution that met the deadline and budget and also had a positive impact throughout the company, from headquarters to customers.

RxS works with companies of all sizes and provides truly client centric solutions that meet each client’s needs. To learn more about RxS offerings please visit rxsinfo.com. To schedule a visit to their new headquarters, please email sales@rxsinfo.com.

About RxS LLC

RxS LLC, a privately held company in Manalapan, New Jersey, is the leading provider of multi-channel sample management solutions for pharmaceutical and biotech companies. Supported by more than   75 years of combined pharmaceutical leadership experience, RxS has been partnering with pharmaceutical and biotech companies since its founding in 2011 to provide regulatory compliance in order to lessen the administrative burden of the Prescription Drug Marketing Act. RxS offerings go beyond regulatory compliance, providing solutions to increase marketing and sample effectiveness. Driven by technology, RxS offers a suite of proprietary services and software solutions to ensure regulatory compliance and maximize analytics data.

# # #

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3fa66210-a0be-4307-b66f-3fc3e92e4361

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2c04c05e-388c-4cc6-a173-cef94eb39845

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47e38a37-f9b1-41d3-883a-9ba03c746912

Drew Deeter

RxS

2153483890

drew@deeterusa.com

RxS moved to new office at 195 Route 9 S., Suite 208, Manalapan, NJ 07726

Interior photo of new RxS home office building.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
12 Nov
VWS
Hold da helt op for en gang hysteri omkring aktiekursen efter 3Q. Det dokumenterer, at der ikke er g..
105
12 Nov
OMXC20
    En af de farligste tilgange til at investere er at tage udgangspunkt i, at man gerne vil være ri..
43
12 Nov
PNDORA
Deres problem er at diverse fonde  baade de som handler den short, men ogsaa de som ejer eller har e..
31
11 Nov
OMXC20
EMEA   Selvom man er uenig med andre mennesker i vitale spørgsmål f.eks. omkring aktier behøver man ..
31
17 Nov
ALMB
Når man dagligt læser indlæg fra Alpehuen, Mackkeith, Malurt, EMEA (MENA), Powertrade som via en flo..
25
16 Nov
NOVO-B
Og Goodwrench, Baronen og marc55
25
11 Nov
OMXC20
EMEA. Jeg har kun een ting at sige til dig EMEA. Hvis du tilbød at arbejde gratis, ville du stadig v..
24
17 Nov
OMXC20
  Her kommer en kort gennemgang og forklaring på, hvorfor aktietilbagekøb både kan være rigtig godt ..
22
13 Nov
BEO-SDB
Godaften, Tomme tønder buldre mest...! Det var vel ikke forventet at vi skulle have RAA og NVV..
21
11 Nov
OMXC20
Optimisten82. Prøv for sjov skyld at følge mig i dette tankesæt. Lad os antage, at du sidder i besty..
20

Alliance Trust PLC : Net Asset Value(s)

17/11/2017 13:20:40
ALLIANCE TRUST PLC                                    At the close of business on Thursday 16 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.8p -       including income, 788.4p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding i..

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

17/11/2017 10:28:48
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Alliance Trust PLC : Net Asset Value(s)

16/11/2017 14:31:51
ALLIANCE TRUST PLC                                    At the close of business on Wednesday 15 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 773.4p -       including income, 782.9p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
VR Resources Provides Corporate Update
2
Cuba Ventures Corp. Blockchain Revolupay identifies CCU Coin Cryptocurrency Data mining center in the Bahamas for possible synergy. CEO Steve Marshall meets with CEO of Stonegate Bank USA.
3
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ford Motor Company of Class Action and Upcoming Deadline – F
4
Doubletree By Hilton Carson Offers Active Duty Military And Veterans An Extra 20 Percent Off ‘Los Angeles Chargers Room And Ride’ Package; Supports Chargers ‘Salute To Service’ On November 19
5
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trivago N.V., Inc. of Class Action Lawsuit and Upcoming Deadline – TRVG

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 November 2017 00:34:16
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB3 - 2017-11-18 01:34:16 - 2017-11-18 00:34:16 - 1000 - Website: OKAY